Physician profile
Jonathan Chodosh Strok
NPI 1225641418
$1,003.15
in general payments reported to CMS, 2019-2025
18 companies · $418 in 2025
The $418 reported for 2025 was more than what 90% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.55 · 2022: $119 · 2023: $332 · 2024: $60.84 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $333.78 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Synclara Cough System, Hillrom - Volara System |
| Genzyme Corporation | $141.33 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $102.38 | 2021-2025 | Trikafta |
| Sarepta Therapeutics, INC. | $64.99 | 2023-2025 | Elevidys |
| Inspire Medical Systems, INC. | $40.04 | 2023 | Inspire |
| Digestive Care, INC. | $39.80 | 2023-2024 | Pertzye |
| Pierre Fabre Pharmaceuticals, INC. | $37.46 | 2023 | Hemangeol |
| Masimo Corporation | $32.34 | 2022 | |
| Mylan Specialty L.P. | $27.25 | 2022 | |
| Insmed, INC. | $25.20 | 2025 | Arikayce |
| Advanced Respiratory, INC | $24.96 | 2021 | |
| Alcresta Therapeutics, INC. | $24.14 | 2023 | Relizorb |
| Philips North America LLC | $21.90 | 2025 | Vest Therapy Und |
| Ns Pharma, INC. | $21.68 | 2025 | Viltepso |
| Ptc Therapeutics, INC. | $19.15 | 2023 | Emflaza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.04 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.19 | 2023 | |
| Arbor Pharmaceuticals, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Strok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.